Have you been newly diagnosed with or suspected of having either acute myelogenous leukemia or high risk myeloid neoplasm? Are you looking for other treatment options? In this study, depending on the specific type of leukemia you have, our study team will determine the different treatment options that we can provide to you.

This is a study for people with colon, pancreatic, Squamous Non-small cell lung cancer, or Squamous cell carcinoma of head and neck. In this study, we want to find out if an investigational drug (Tisotumab Vedotin) is effective for people with solid tumors.

This is a research study for people diagnosed with AML. The purpose of this study is to see if the treatment of a combination of two drugs (cytarabine liposome therapy) and adding a third drug (pomalidomide) in different doses is more effective.

Do you currently have a solid tumor that has advanced or progressed after treatment with a PARP inhibitor? Does your tumor have genetic abnormalities in the system that repairs damage to DNA? If so, you may be able to take part in a research study to see if a new drug will be able to slow the growth of your cancer. Travel reimbursement and compensation provided if eligible for participation.

If you have been diagnosed with melanoma and need surgery to remove it, you may be able to take part in a research study. In this study, we want to learn whether a smaller incision during melanoma surgery is better or worse than the usual standard of care.

Do you have head and neck cancer or soft tissue sarcoma? Are you planning to have surgery to remove your tumor? You may be able to participate in a research study to determine which therapies may be best for future patients. Compensation provided.

To explore possible reasons for low registration of students to the LCTLs at UNC

In this study, we want to learn how we can increase awareness and availability of specialty pain care services for Black men. We will do this by asking questions about physical health, access to health care, decision-making, and factors that impact someone's health.

The purpose of this study is to look at the effectiveness of a combination of treatments, polatuzumab vedotin with rituximab, gemcitabine, dexamethasone, and cisplatin (PV-RGDP) at treating relapsed or refractory diffuse large B-cell lymphoma.

In this study, we want to learn more about the impact of micro-influencers on young adults between ages 18 and 25.